Can we use B-type natriuretic peptides to monitor patients with heart failure?

被引：0
|
作者：
McDonagh, Theresa A. [1 ]
Gardner, Roy S. [2 ]
Chong, Kwok S. [3 ]
Dargie, Henry J. [2 ]
机构：
[1] Royal Brompton Hosp, London SW3 6LY, England
[2] Glasgow Royal Infirm, Scottish Natl Adv Heart Failure Serv, Glasgow G4 0SF, Lanark, Scotland
[3] So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland
来源：
BIOMARKERS IN MEDICINE | 2007年 / 1卷 / 03期
关键词：
heart failure; monitoring; natriuretic peptides; treatment titration;
D O I：
10.2217/17520363.1.3.349
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The B-type natriuretic peptides (BNPs) now have a well-established role in the diagnosis of heart failure. There is also a wealth of evidence on their ability as prognostic markers in patients with heart failure. The other potential role of BNPs is in the arena of therapy monitoring, although much less is known regarding this putative application. This review summarizes what evidence there is both for and against using BNPs to monitor heart failure patients.
引用
收藏
页码：349 / 353
页数：5
相关论文
共 50 条
  • [31] Urinary B-type natriuretic peptide levels in heart failure
    Rivera Otero, M.
    Cortes, R.
    Garcia De Burgos, F.
    Almenar, L.
    Salvador, A.
    Orosa, P.
    Mora, V.
    Portoles, M.
    EUROPEAN HEART JOURNAL, 2007, 28 : 415 - 415
  • [32] B-type natriuretic peptide for the treatment of congestive heart failure
    Schreiner, GF
    Protter, AA
    CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (02) : 142 - 147
  • [33] The role of b-type natriuretic peptide in heart failure management
    Newton, Phillip J.
    Betihavas, Vasiliki
    Macdonald, Peter
    AUSTRALIAN CRITICAL CARE, 2009, 22 (03) : 117 - 123
  • [34] The role of the B-type natriuretic peptide in the chronic heart failure
    Lazzerini, S
    Minneci, C
    Martelli, C
    Sarti, A
    Verdelli, M
    Doni, L
    CLINICA CHIMICA ACTA, 2005, 355 : S125 - S125
  • [35] Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure
    Rosenberg, Jens
    Gustafsson, Finn
    Remme, Willem J.
    Riegger, Guenter A. J.
    Hildebrandt, Per Rossen
    CARDIOVASCULAR DRUGS AND THERAPY, 2008, 22 (04) : 305 - 311
  • [36] Plasma B-type natriuretic peptide in children with heart failure
    Connolly, D
    Roots, K
    McGuire, S
    Artman, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 328A - 328A
  • [37] Effect of Beta-blockade and ACE Inhibition on B-type Natriuretic Peptides in Stable Patients with Systolic Heart Failure
    Jens Rosenberg
    Finn Gustafsson
    Willem J. Remme
    Günter A. J. Riegger
    Per Rossen Hildebrandt
    Cardiovascular Drugs and Therapy, 2008, 22
  • [38] Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure
    Seronde, Marie-France
    Gayat, Etienne
    Logeart, Damien
    Lassus, Johan
    Laribi, Said
    Boukef, Riadh
    Sibellas, Franck
    Launay, Jean-Marie
    Manivet, Philippe
    Sadoune, Malha
    Nouira, Semir
    Solal, Alain Cohen
    Mebazaa, Alexandre
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 3404 - 3411
  • [39] Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure
    Seronde, M-F
    Gayat, E.
    Logeart, D.
    Lassus, J.
    Laribi, S.
    Boukef, R.
    Sibellas, F.
    Launay, J. M.
    Cohen-Solal, A.
    Mebazaa, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S117 - S117
  • [40] Prognosis of Stage A or B Heart Failure Patients With Elevated B-type Natriuretic Peptide Levels
    Daniels, Lori B.
    Clopton, Paul
    Jiang, Kevin
    Greenberg, Barry
    Maisel, Alan S.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (02) : 93 - 98
12345